Membranous nephropathy: Treatment outline and risk stratification
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adult. However, the exact etiology and the best treatment approach are still unclear. It is imperative to understand the nature of and prognosis of MN before initiating treatment which may include disease specific therapy...
Guardado en:
Autor principal: | Ziad Arabi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4253f30514b485abf43b61deeedabb8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria
por: Peng He, et al.
Publicado: (2021) -
IgA Nephropathy Secondary to Ipilimumab Use
por: Sean C. Dougherty, et al.
Publicado: (2021) -
Membranous nephropathy with pulmonary cryptococcosis with improved 1-year follow-up results: A case report
por: Zhang Peipei, et al.
Publicado: (2021) -
Hydroxychloroquine in IgA nephropathy: a systematic review
por: Gabriel Stefan, et al.
Publicado: (2021) -
How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy
por: Tiffany N. Caza, et al.
Publicado: (2021)